Factor structure of paranoid schizophrenia: A prospective study

Psychopathology

Volumn 36, Issue 3, 2003, Pages 132-141

  Loza, Bartosz ^a   Kucharska Pietura, Katarzyna ^a   Kopacz, Grzegorz ^a   Debowska, Grazyna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Dimensionality; Factor model; Paranoid schizophrenia

Indexed keywords

ADULT; COGNITION; CONFERENCE PAPER; CONTROLLED STUDY; DEPRESSION; DISEASE MODEL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARANOID SCHIZOPHRENIA; PROSPECTIVE STUDY; SYMPTOM; TECHNOLOGY;

ADULT; COGNITION DISORDERS; DEPRESSIVE DISORDER; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MODELS, STATISTICAL; PATIENT ADMISSION; PATIENT DROPOUTS; PATIENT READMISSION; PRINCIPAL COMPONENT ANALYSIS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA, PARANOID;

EID: 0037971881     PISSN: 02544962     EISSN: None     Source Type: Journal    
DOI: 10.1159/000071258     Document Type: Conference Paper

References (30)

1. Crow T: Molecular pathology of schizophrenia: More than one disease process? Br Med J 1980;280:66-68.
2. Andreasen NC, Olsen S: Negative vs. positive schizophrenia: Definition and validation. Arch Gen Psychiatry 1982;39:789-794.
3. Smith DA, Mar CM, Turoff BK: The structure of schizophrenic symptoms: A meta-analytic confirmatory factor analysis. Schizophr Res 1998;31:57-70.
4. Stuart GW, Pantelis C, Klimidis S, Minas IH: The three-syndrome model of schizophrenia: Meta-analysis of an artefact. Schizophr Res 1999;39:233-242.
5. White L, Harvey PD, Opler L, Lindenmayer JP, PANSS Study Group: Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. Psychopathology 1997;30:263-274.
6. Peralta V, Cuesta MJ: How many and which are the psychopathological dimensions in schizophrenia? Issues influencing their ascertainment. Schizophr Res 2001;49:269-285.
7. Toomey R, Kremen W, Simpson J, Samson J, Seidman L, Lyons M, Faraone S, Tsuang M: Revisiting the factor structure for positive and negative symptoms: Evidence from a large heterogeneous group of psychiatric patients. Am J Psychiatry 1997;154:371-377.
8. Andreasen NC, Flaum M, Schultz S, Duzyurek S, Miller D: Diagnosis, methodology and subtypes of schizophrenia. Neuropsychobiology 1997;35:61-63.
9. Lancon C, Auquier P, Nayt G, Reine G: Stability of the five-factor structure of the Positive and Negative Syndrome Scale (PANSS). Schizophr Res 2000;42:231-239.
10. Lindenmayer JP, Grochowski S, Mabugat L: Clozapine effects on positive and negative symptoms: A six-month trial in treatment refractory schizophrenics. J Clin Psychopharmacol 1994;14:201-204.
11. Marder SR, Davis JM, Chouinard G: The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: Combined results of the North American trials. J Clin Psychiatry 1997;58:538-546.
12. Von Knorring L, Lindström E: Principal components and further possibilities with the PANSS. Acta Psychiatr Scand Suppl 1995;388:5-10.
13. Lykouras L, Oulis P, Psarros K, Daskalopoulou E, Botsis A, Christodoulou G, Stefanis C: Five-factor model of schizophrenic psychopathology: How valid is it? Eur Arch Psychiatry Clin Neurosci 2000;250:93-100.
14. Mass R, Schoemig T, Hitschfeld K, Wall E, Haasen C: Psychopathological syndromes of schizophrenia: Evaluation of the dimensional structure of the positive and negative syndrome scale. Schizophr Bull 2000;26:167-177.
15. Peralta V, Cuesta MJ: Dimensional structure of psychotic symptoms: An item-level analysis of SAPS and SANS symptoms in psychotic disorders. Schizophr Res 1999;38:13-26.
16. McGlashan TH, Fenton WS: Classical subtypes for schizophrenia: Literature review for DSM-IV. Schizophr Bull 1991;17:609-632.
17. Zalewski C, Johnson-Selfridge MT, Ohriner S, Zarrella K, Seltzer JC: A review of neuropsychological differences between paranoid and nonparanoid schizophrenia patients. Schizophr Bull 1998;24:127-145.
18. Carpenter WT, Arango C, Buchanan RW, Kirkpatrick B: Deficit psychopathology and a paradigm shift in schizophrenia research. Biol Psychiatry 1999;46:352-360.
19. Hori A, Tsunashima K, Watanabe K, Takekawa Y, Ishihara I, Terada T, Uno M: Symptom classification of schizophrenia changes with the duration of illness. Acta Psychiatr Scand 1999;99:447-452.
20. Salokangas RKR: Structure of schizophrenic symptomatology and its changes over time: Prospective factor-analytical study. Acta Psychiatr Scand 1997;95:32-39.
21. Nakaya M, Suwa H, Ohmori K: Latent structures underlying schizophrenic symptoms: A five-dimensional model. Schizophr Res 1999;39:39-50.
22. Kulhara P, Kota SK, Joseph S: Positive and negative subtypes of schizophrenia. A study from India. Acta Psychiatr Scand 1986;74:353-359.
23. Rey ER, Bailer J, Brauer W, Handel M, Laubenstein D, Stein A: Stability trends and longitudinal correlations of negative and positive syndromes within a three-year follow-up of initially hospitalized schizophrenics. Acta Psychiatr Scand 1994;90:405-412.
24. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, APA, 1994.
25. Kay S, Fiszbein A, Opler L: The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276.
26. Bazire S: Psychotropic drug directory. Snow Hill, Mark Allen, 2000, pp 136-137.
27. Müller MJ, Szegedi A, Wetzel H, Benkert O: Depressive factors and their relationships with other symptom domains in schizophrenia, schizoaffective disorder, and psychotic depression. Schizophr Bull 2001;27:19-28.
28. Loftus J, DeLisi LE, Crow TJ: Factor structure and familiarity of first-rank symptoms in sibling pairs with schizophrenia and schizoaffective disorder. Br J Psychiatry 2000;177:15-19.
29. Bryson G, Bell M, Greig T, Kaplan E: Internal consistency, temporal stability and neuropsychological correlates of three cognitive components of the positive and negative syndrome scale (PANSS). Schizophr Res 1999;38:27-35.
30. Dollfus S, Petit M, Lessieur P, Menard JP: Principal component analysis of PANSS and SANS-SAPS global ratings in schizophrenic patients. Eur Psychiatry 1991;6:251-259.